A case-control study of maternal periconceptual and pregnancy recreational drug use and fetal malformation using hair analysis

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  David, Anna L ^a   Holloway, Andrew ^a   Thomasson, Louise ^a   Syngelaki, Argyro ^b   Nicolaides, Kypros ^a,b   Patel, Roshni R ^c   Sommerlad, Brian ^d   Wilson, Amie ^e   Martin, William ^e   Chitty, Lyn S ^f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c ST MICHAEL'S HOSPITAL   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; RECREATIONAL DRUG; STREET DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CENTRAL NERVOUS SYSTEM MALFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; FEMALE; FETUS; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; GASTROSCHISIS; HAIR ANALYSIS; HAIR ROOT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MATERNAL AGE; PREGNANT WOMAN; SECOND TRIMESTER PREGNANCY; SOCIAL ASPECT; UMBILICAL HERNIA; ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS; CHEMISTRY; CLINICAL TRIAL; CONGENITAL MALFORMATION; ENVIRONMENTAL EXPOSURE; FETOMATERNAL TRANSFUSION; HAIR; MIDDLE AGED; MULTICENTER STUDY; PREGNANCY; SUBSTANCE ABUSE; YOUNG ADULT;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS; FEMALE; FETUS; GASTROSCHISIS; HAIR; HUMANS; MATERNAL AGE; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; STREET DRUGS; SUBSTANCE ABUSE DETECTION; YOUNG ADULT;

EID: 84910021485     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111038     Document Type: Article

References (32)

1. Chief Medical Officer's Annual Report (2004) Gastroschisis: a growing concern. London: Department of Health.
2. Tan KH, Kilby MD, Whittle MJ, Beattie BR, Booth IW, et al. (1996) Congenital anterior abdominal wall defects in England and Wales 1987-93: retrospective analysis of OPCS data. BMJ 313: 903-936.
3. Torfs CP, Velie EM, Oechsli FW, Bateson TF, Curry CJ (1994) A population-based study of gastroschisis: demographic, pregnancy and lifestyle factors. Teratology 50: 44-53.
4. Hume RF Jr, Gingras JL, Martin LS, Hertzberg BS, O'Connell K, et al. (1994) Ultrasound diagnosis of fetal anomalies associated with in utero cocaine exposure: further support for cocaine-induced vascular disruption teratogenesis. Fet Diagn Ther 9: 239-245.
5. Grant T, Brown Z, Callahan C, Barr H, Streissguth AP (1994) Cocaine exposure during pregnancy: improving assessment with radioimmunoassay of maternal hair. Obstet Gynecol 83: 524-531.
6. Kline J, Ng SK, Schittini M, Levin B, Susser M (1997) Cocaine use during pregnancy: sensitive detection by hair assay. Am J Pub Hlth 87: 352-358.
7. Villain M, Cirimele V, Kintz P (2004) Hair analysis in toxicology. Clin Chem Lab Med 42: 1265-1272.
8. Morrison JJ, Chitty LS, Peebles D, Rodeck CH (2005) Recreational drugs and fetal gastroschisis: maternal hair analysis in the peri-conceptional period and during pregnancy. BJOG 112: 1022-1025.
9. Webster WS, Brown-Woodman PD (1990) Cocaine as a cause for congenital malformations of vascular origin: experimental evidence in the rat. Teratology 41: 689-697.
10. Yamamoto Y, Yamamoto K, Fukui Y, Kurishita A (1992) Teratogenic effects of metamphetamine in mice. Nippon Hoigaku Zasshi 46: 126-131.
11. Colado ML, O'Shea E, Granados R, Misra A, Murray TK, et al. (1997) A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Br J Pharmacol 121: 827-833.
12. He N, Lidow MS (2004) Cerebral cortical abnormalities seen in non-human primate model of prenatal cocaine exposure are not related to vasoconstriction. Neurotoxicology 25: 419-432.
13. Plessinger MA (1998) Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am 25: 119-38.
14. Nora JJ, Vargo TA, Nora AH, Love KE, McNamara DG (1970) Dexamphetamine: a possible environmental trigger in cardiovascular malformations. Lancet 1: 1290-1291.
15. Bays J (1994) Fetal vascular disruption with prenatal exposure to cocaine or metamphetamine. Pediatrics 87: 416-8.
16. Lipshultz SE, Frassiac JJ, Orav EJ (1991) Cardiovascular abnormalities in infants prenatally exposed to cocaine. J Pediatr 118: 44-51.
17. Kashiwagi M, Chaoui R, Stallmach T, Hurlimann S, Lauper U, et al. (2003) Fetal bilateral renal agenesis, phocomelia, and single umbilical artery associated with cocaine abuse in early pregnancy. Birth Defects Res A Clin Mol Teratol 67: 951-952.
18. Markov D, Jacquemyn Y, Leroy Y (2003) Bilateral cleft lip and palate associated with increased nuchal translucency and maternal cocaine abuse at 14 weeks of gestation. Clin Exp Obstet Gynecol 30: 109-110.
19. Werler MM, Sheehan JE, Mitchell AA (2003) Association of vasoconstrictive exposures with risks of gastroschisis and small intestinal atresia. Epidemiology 14: 349-354.
20. Hume RF Jr, Martin LS, Bottoms SF, Hassan SS, Banker-Collins K, et al. (1997) Vascular disruption birth defects and history of prenatal cocaine exposure: A case control study. Fet Diagn Ther 12: 292-295.
21. Klein J, Karaskov T, Koren G (2000) Clinical applications of hair testing for drugs of abuse - the Canadian experience. Forensic Sci Int 107: 281-288.
22. Spiehler V (2000) Hair analysis by immunological methods from the beginning to 2000. Forensic Sci Int 107: 249-259.
23. Nakahara Y, Shimamine M, Takahashi K (1992) Hair analysis for drugs of abuse. III. Movement and stability of metoxyphenamine (as a model compound of methamphetamine) along hair shaft with hair growth. J Analytic Toxicol ; 16: 253-257.
24. Miyazawa N, Uematsu T (1992) Analysis of ofloxacin in hair as a measure of hair growth and as a time marker for hair analysis. Ther Drug Monit 14: 525-528.
25. Draper ES, Rankin J, Tonks AM, Abrams KR, Field DJ, et al. (2008) Recreational drug use: a major risk factor for gastroschisis? Am J Epidemiol 167: 485-491.
26. Dominguez R, Aguirre Vila-Coro A, Slopis JM, Bohan TP (1991) Brain and ocular abnormalities in infants with in utero exposure to cocaine and other street drugs. Am J Dis Child 145: 688-695.
27. Orrico A, Galli L, Zappella M, Monti L, Vatti GP, et al. (2002) Septo-optic dysplasia with digital anomalies associated with maternal multidrug abuse during pregnancy. Eur J Neurol 9: 679-682.
28. Beaty TH, Wang H, Hetmanski JB, Fan YT, Zeiger JS, et al. (2001) A case-control study of non-syndromic oral clefts in Maryland. Ann Epidemiol 11: 434-442.
29. Bower C, Miller M, Payne J, Serna P (2006) Folate intake and the primary prevention of non-neural birth defects. Aust NZ J Public Health 30: 258-261.
30. Godwin KA, Sibbald B, Bedard T, Kuzeljevic B, Lowry RB, et al. (2008) Changes in frequencies of select congenital anomalies since the onset of folic acid fortification in a Canadian birth defect registry. Canadian J Pub Hlth 99: 71-75.
31. Huestis MA, Choo RE (2002) Drug abuse's smallest victims: in utero drug exposure. For Sci Int 2002; 128: 20
32. Paranjothy S, Broughton H, Evans A, Huddart S, Drayton M, et al. (2012) The role of maternal nutrition in the aetiology of gastroschisis: an incident case-control study. Int J Epidemiol41: 1141-1152.